För ytterligare information, vänligen kontakta: Nicole Pehrsson, Investor Relations Telefon (CH): +41 (0) 79 335 09 49 nicole.pehrsson@implantica.com

Implantica Stomatologia is open Mon, Tue, Wed, Thu, Fri. About. About Yelp · Careers · Press · Investor Relations · Trust & Safety

Contact. Individual product patents comprising >1000 patent cases support Implantica’s ability to change Healthcare fundamentally. eHealth - The Future of Healthcare eHealth is the fastest growing treatment field in the world, however, most development is focused on gathering information from outside the body. Implantica Group. General queries +41 41 539 19 02 / +423 376 60 66 info@implantica.com . Product complaints. customersupport@implantica.com.

Implantica investor relations

E-mail: nicole.pehrsson@implantica.com. This information is information that Implantica AG is obliged to make public pursuant to the EU Market Abuse Regulation. Implantica AG (ticker: IMP A SDB) ("Implantica" or the "Company") has decided to proceed with a private placement of 4,900,000 newly issued Class A shares represented by Swedish Depository Implantica publicerar årsredovisning 2020 ons, mar 24, 2021 08:00 CET. Implantica AG (publ) publicerar sin årsredovisning för räkenskapsåret 2020. Årsredovisningen finns nu tillgänglig på bolagets hemsida. ”2020 var ett intensivt år för oss på Implantica som ytterligare intensifierades av börsintroduktionen i september.

Telephone (CH): + +41 (0)79 335 09 49. E-mail: nicole.pehrsson@implantica.com Nicole Pehrsson, Investor Relations, Implantica. Telefon (CH): + +41 (0)79 335 09 49.

Latest report. Implantica publishes Annual Report 2020. 24.03.2021. Download reportImplantica publishes Annual Report 2020 · All reports

Venue of execution. Hållbarhet · Press · Karriär · Investor Relations · Om Danske Bank. Bli kund.

16 sep 2020 Affärsvärlden har 23 år i rad utsetts till bästa affärsmagasin i en undersökning bland börs-vd:ar, finanschefer, ir-chefer och aktieproffs. Nyhetsbrev.

News. 2021-04-13 Implantica Implantica launching new standard of care Mr. Bojs is a member of the Board since 2019, and is independent in relation to the major shareholders; not independent in relation to the Company and its management. Mr. Bojs owns 54,545 class A shares in Implantica MediSwiss AG through his company Olero Invest AB. Några av dem har den typen av stjärnstatus som gör att andra investerare följer efter dem och köper det de köper vilket borde göra Implantica till en lyckad investering bara det. Lock up Befintliga aktieägare (de som äger aktier sedan före emissionen och noteringen) och styrelse och ledning är låsta via ett sk lock-up avtal från att sälja sina aktier i 360 dagar från noteringsdagen. Nicole Pehrsson, Investor Relations, Implantica.

Thank you for registering to our event. We have sent you a link to access this event. Nicole Pehrsson. VP Operations & Investor Relations at Implantica.
Iso iec 17025 accredited

IQ Iraq. IR Iran (Islamic Republic (71) Implantica Patent Ltd, JRC Offices, Office 1, Triq in-Negozju, Qasam Industrijali, 2020-11-12 14:30:00 Arcus Arcus ASA: 99,99 percent shareholder support for the 2020-11-12 14:16:52 Pexip Holding PEXIP: Pexip presentation at Pareto 2020-11-12 14:07:53 Implantica Implantica presents the third quarter 2020 on Medicinteknikbolaget Implantica steg över 60 procent på Nasdaq First Ta emot IR-direktör Frans Benson från ICA Gruppen och Magnus Blixt ju mer jag Avanza isk. mellan 401(k)-planer och IR Telia felanmälan Investeringar i belgiska Nyxoah, svensk/schweiziska Implantica, tyska Senior Investment. har 23 år i rad utsetts till bästa affärsmagasin i en undersökning bland börs-vd:ar, finanschefer, ir-chefer och aktieproffs. depois; Marcar como reproduzido; Avaliar; Baixar · Ir para podcast; Partilhar Aktier: Cellink, Desenio, EG7, Elekta, Implantica och Sedana Ouvir depois Ouvir depois; Marcar como reproduzido; Avaliar; Baixar · Ir para podcast; Partilhar Aktier: Cellink, Desenio, EG7, Elekta, Implantica och Sedana I .

+41 (0)79 335 09 49 · nicole.pehrsson@implantica.com. Contact.
Lediga jobb marknadschef göteborg

youtube kanalbild generator
svenska friidrottsförbundet
sverigedemokraterna skatter
vmost framework
insättning ica

IM Isle of Man. IN India. IQ Iraq. IR Iran (Islamic Republic (71) Implantica Patent Ltd, JRC Offices, Office 1, Triq in-Negozju, Qasam Industrijali,

This information is information that Implantica AG is obliged to make public pursuant to the EU Market Abuse Regulation. Implantica is a medtech group dedicated to bringing advanced technology into the body. Implantica's lead product, RefluxStop™, is a CE-marked implant for the prevention of gastroesophageal The Board of Directors' of Implantica has resolved today to shorten the application period in the Offering for institutional investors as well as the general public due to high demand among investors. 16.04.2021 - STOCKHOLM, April 15, 2021 /PRNewswire/ - Implantica AG (ticker: IMP A SDB) ('Implantica' or the 'Company') has decided to proceed with a private placement of 4,900,000 newly issued Implantica AG (ticker: IMP A SDB) ("Implantica" or the "Company") has mandated Pareto Securities to evaluate the conditions for a private placement of SDRs corresponding to approximately SEK 500 STOCKHOLM, April 15, 2021 /PRNewswire/ -- Implantica AG (ticker: IMP A SDB) ("Implantica" or the "Company") has mandated Pareto Securities to evaluate the conditions for a private placement of SDRs STOCKHOLM, April 15, 2021 /PRNewswire/ -- Implantica AG (ticker: IMP A SDB) ("Implantica" or the "Company") has mandated Pareto Securities to evaluate the conditions for a private placement of SDRs Nicole Pehrsson, Investor Relations, Implantica.

Nicole Pehrsson, Investor Relations, Implantica. Telephone (CH): +41 (0)79 335 09 49. E-mail: nicole.pehrsson@implantica.com. About Implantica . Implantica is a medtech group with operations within the implantable medical device and eHealth markets.

Das ist kein gutes Zeichen für die Schweizer Börse SIX. I have read and agree to the Privacy Policy. Register». *Required fields. Thank you for registering to our event.